68 SUNDAY • MAY 15 P616 P617 P618 Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Adults /K.M. Sullivan, M.L.A. Daniels, J.J. Atkinson, T.W. Ferkol, D. Hall, H.-S. Lee, H. Metjian, K.N. Olivier, M. Rosenfeld, C.E. Milla, M. Zariwala, S.D. Sagel, J. Carson, J. Krischer, M. Hazucha, M. Knowles, M. Leigh, Genetics Disorders Of Mucociliary Clearan, p.A1765 Determinants of Respiratory Function in Adults Patients with Primary Ciliary Dyskinesia/J. Frija-Masson, L. Bassinet, I. Honore, N. Dufeu, B. Housset, A. Coste, J.-F. Papon, E. Escudier, P.-R. Burgel, B. Maitre, Creteil, France, p.A1766 Maximal Mid-Expiratory Flow Is a Surrogate Marker of Lung Clearance Index for Assessment of Adults with Bronchiectasis/W.-J. Guan, J.-J. Yuan, Y.-H. Gao, H.-M. Li, J.-P. Zheng, R. Chen, N. Zhong, Guangzhou, China, p.A1767 P619 Baseline Demographic Profile of Subjects of the Phase 3 RESPIRE 2 Trial of Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-Cystic Fibrosis Bronchiectasis (NCFB)/T.R. Aksamit, A. De Soyza, E. Operschall, T.-J. Bandel, U. Krahn, E. Montegriffo, M. Criollo, R.C. Wilson, Rochester, MN, p.A1768 P620 P621 Facilitator: P622 P623 P624 P625 P626 Prevalence of Airflow Limitation in Patients with Bronchiectasis, and Its Effect on Acute Exacerbation and the Decline of Lung Function/J.-M. Kim, S.M. Choi, J. Lee, Y.S. Park, C.-H. Lee, S.-M. Lee, J.-J. Yim, Y.W. Kim, S.K. Han, C.-G. Yoo, Seoul, Korea, Republic of, p.A1769 Relationship Between Airway Inflammatory Biomarkers and Functional Status in Non-Cystic Fibrosis Bronchiectasis/M.A. Roggi, F.L. Dente, M. Latorre, M. Bilotta, D. Nieri, M.L. Bartoli, S. Cianchetti, B. Vagaggini, P. Paggiaro, Pisa, Italy, p.A1770 N.M. Quesada, MD, Chicago, IL Acute Exacerbations of Non-Cystic Fibrosis Bronchiectasis: What Can Promise Non-Invasive Ventilation for Patients with Type 2 Respiratory Failure?/A. Sadigov, S. Akhundov, F. Abdullayev, Baku, Azerbaijan, p.A1771 Pseudomonas Colonization, Lung Function, Computed Tomography, and Macrolides in Non-Cystic Fibrosis Bronchiectasis: What Can We Wait from These Dates?/A. Sadigov, G. Sadigova, S. Huseynova, I. Ashirova, Baku, Azerbaijan, p.A1772 The Relationship Between Vitamin D Levels and Lung Function, Clinical Indices, Depression and Anxiety Symptoms in Adult Patients with Non-Cystic Fibrosis Bronchiectasis/M. Bekir, D. Kocakaya, S. Olgun Yildizeli, H. Arikan, E. Eryuksel, B. Bagci Ceyhan, Istanbul, Turkey, p.A1773 Non-Cystic Fibrosis Bronchiectasis in Patients with Hematologic Malignancy/L.W. Chen, W.B. Karkowsky, S. Montner, P.J. McShane, S.R. White, M.E. Strek, Chicago, IL, p.A1774 ORBIT-3 and ORBIT-4: Design of a Phase 3 <strong>Program</strong> to Investigate Safety and Efficacy of Pulmaquinr in Non-Cystic Fibrosis Bronchiectasis (NCFBE) Patients Chronically Colonized with Pseudomonas Aeruginosa (PA)/A. O’Donnell, D. Bilton, D. Serisier, A. Wanner, J. Froehlich, P. Bruinenberg, I. Gonda, Washington, DC, p.A1775 P627 P628 P629 P630 P631 P632 P633 Facilitator: P634 P635 P636 P637 P638 P639 P640 Profile of Exacerbations Among Patients with Non-Cystic Fibrosis Bronchiectasis at the State University of Rio de Janeiro/R.K.R. Leal, R.E.B. Salles, W. Costa, A.B.A. Silva, T.F. Cruz, B.R.A. Silva, Rio de Janeiro, Brazil, p.A1776 Respiratory Failure After Bronchial Arterial Embolization in Patients with Cystic Fibrosis: An Institutional Review/J.A. Town, M.L. Aitken, Seattle, WA, p.A1777 Procalcitonin Levels in Cystic Fibrosis Exacerbations/G. Loh, A. Skabelund, A. French, J. Morgan, San Antonio, TX, p.A1778 Perfluorinated Gas MRI to Detect Regional Ventilation Heterogeneity in Cystic Fibrosis/J.L. Goralski, E.O. Akinnagbe, C. Salazar, R.C. Boucher, Y.Z. Lee, S. Donaldson, Chapel Hill, NC, p.A1779 Use of Ultra-Low Dose Chest Computed Tomography Scanning to Detect Emphysema in Patients with Cystic Fibrosis/G. Dalgleish, H. Sahi, K. Lau, C. Daley, D. Garner, P. King, Clayton, Australia, p.A1780 Atlas-Based Analysis of MRI Measures of Lung Water Density to Identify Regional Lung Abnormalities in CF Adults/ R.J. Theilmann, A.R. Elliott, C. Darquenne, D.J. Conrad, La Jolla, CA, p.A1781 The Impact of Aspergillus Fumigatus and Its Treatment on Outcomes in Cystic Fibrosis/T. Basnayake, F. Finlayson, A. Peleg, J. Wilson, T. Kotsimbos, Prahran, Australia, p.A1782 E.T. Naureckas, MD, Chicago, IL The Genetic Profile of Chinese Patients with Cystic Fibrosis/X. Tian, Y. Liu, X. Li, X. Zhang, K.-F. Xu, Beijing, China, p.A1783 Fenretinide Normalizes Aberrant Lipid Metabolism and Prevents Excessive Inflammation During Pulmonary Exacerbation in Adult Cystic Fibrosis Patients/D. Radzioch, G. Wojewodka, S. Cupri, P. Colin, R. Pislariu, D. Garic, I. Kianicka, E. Matouk, Montreal, Canada, p.A1784 How does CPET Compared to Yearly Lung Function Follow-Up in Adult Cystic Fibrosis Patients/T.S. Hynes, P. Harnett, B. Casserly, Limerick, Ireland, p.A1785 Severity Index in Pulmonary Exacerbations in Cystic Fibrosis/L. Diab, R.M. Giron, E. Garcia, C. Marcos, M. Hernandez, J.L. Justicia, C. Acosta, J. Ancochea, Madrid, Spain, p.A1786 Nebulizer Aerosol Performance and Patient Acceptance in Cystic Fibrosis/C. Landon, G. Garza, Ventura, CA, p.A1787 Study Design: Effects of Long Term TobrAmycin Inhalation Solution (TIS) Once Daily on Exacerbation Rate in Patients with Non-Cystic Fibrosis Bronchiectasis. A Double Blind, Randomized, Placebo and TIS Twice Daily (open label) Controlled Trial. The BATTLE/L. Terpstra, J. Altenburg, R. Duijkers, W.G. Boersma, Alkmaar, Netherlands, p.A1788 Epidemiology And Natural History of Pseudomonas aeruginosa Infection in Patients with Non-Cystic Fibrosis Related Bronchiectasis/R. Lim, T. Woo, J. Duong, B. Waddell, C. Mody, H. Rabin, D.G. Storey, M.D. Parkins, Calgary, Canada, p.A1789 ATS 2016 • San Francisco
SUNDAY • MAY 15 69 P641 P642 P643 Prevalence of Mycobacterial Infection in Adult Brazilian Patients with Cystic Fibrosis/E.P. Oliveira, A.N. Costa, Sao Paulo, Brazil, p.A1790 Clinical Analysis of The Aspiration Pneumonia in Which Percutaneous Endoscopic Gastrostomy Was Constructed: Our 10-year Experience/H. Tomioka, S. Yamahita, T. Kamada, H. Takata, N. Mamesaya, K. Furuta, Y. Kida, M. Kaneko, Kobe, Japan, p.A1791 DNA Extraction from Cystic Fibrosis Sputum Samples is Not Method Dependent/M.C. Tracy, A. Yacob, C. Chen, C.E. Milla, D.N. Cornfield, Palo Alto, CA, p.A1792 P644 Airway Microbiome Prior To M. Abscessus Complex Or M. Avium Complex Infections In Cystic Fibrosis/L. Caverly, A. Forde, J. LiPuma, Ann Arbor, MI, p.A1793 P645 P646 P647 A52 The Impact of Persistent Growth of Non-tuberculous Mycobacteria on Rate of Lung Function Decline in Adults with Cystic Fibrosis/G. Kirkpatrick, B. Quon, Vancouver, Canada, p.A1794 QBW251 Is a Safe and Efficacious CFTR Potentiator for Patients with Cystic Fibrosis/S. Kazani, J. Alcantara, L. Debonnett, J. Doucet, I. Jones, K. Kulmatycki, S. Machineni, L. Mostovy, I. Nicholls, R. Vegesna, J. Verheijen, D.J. Rowlands, Cambridge, MA, p.A7789 Lumacaftor/Ivacaftor: An Observational Study of Outcomes and Tolerances in Patients with Cystic Fibrosis/M.T. Jennings, R. Dezube, G. Hong, N.E. West, A. Braun, C. Merlo, N. Lechtzin, Baltimore, MD, p.A7790 THEMATIC POSTER SESSION CRITICAL CARE: ICU PROCEDURES, PROCESSES OF CARE, AND NOVEL TECHNIQUES 9:00 a.m. - 4:15 p.m. MOSCONE CENTER Viewing: Posters will be on display for entire session. Area H, Hall D (North Building, Lower Level) Discussion: 11:00-11:45: authors will be present for individual discussion 11:45-12:45: authors will be present for discussion with assigned facilitators Facilitators: D. Park, MD, Seattle, WA E.J. Schenck, MD, New York, NY P897 P898 The Diagnostic Yield, Safety, and Impact of Flexible Bronchoscopy in Non-HIV Immunocompromised Critically Ill Patients in the Intensive Care Unit/M.O. Al-Qadi, R. Cartin-Ceba, R. Kashyap, S. Kaur, S. Peters, Providence, RI, p.A1795 Safety, Feasibility, and Cellular Recovery of Serial Bronchoscopic Alveolar Lavage in Patients with ARDS in the Modern Era/A. Koch, M. Sanchez, L. Flores, C. Thompson, L. Purcell, K. Gibbs, R.N. Bakhru, P. Morris, D.C. Files, Winston-Salem, NC, p.A1796 P899 P900 P901 P902 P903 P904 P905 P906 A New Method for Measuring Oxygen Consumption (VO2): Avoiding the Need for Flow and Oxygen Signals Synchronization/ R.S. Nobrega, P.J.C. Biselli, Sao Paulo, Brazil, p.A1797 Oral Care Kits Used During Mechanical Ventilation in the Intensive Care Unit (ICU): A Retrospective Comparison of Outcomes/M.N. Dubosky, F.A. Turkestani, J. Dietz, Y. Kim, D.L. Vines, Chicago, IL, p.A1798 Accuracy of Oscillometric Blood Pressure Monitoring in Obese Critically Ill Patients Receiving Vasopressors/O. Okoye, C. Long, M. Delk, K. Eissa, F. Simeone, F. Kheir, New Orleans, LA, p.A1799 Impaired Brachial Artery Reactive Hyperemia in Critical Illness/T. Bice, G. Tsang, O. Wexler, J. Meyer, D. Oldfield, K. Falkner, A.P. Pietropaoli, Rochester, NY, p.A1800 Difference in Humidification when Comparing Two Heaters/R.L. Glancy, D.L. Vines, J. Li, Chicago, IL, p.A1801 Evaluation on the Safety and Effectiveness of Manual Rapid Flow Expulsion Maneuver to Clear Subglottic Secretion: A Vitro and Vivo Study/J. Li, Y. Zong, Q. Zhou, N. Wan, B. Sun, H. Dai, C. Wang, Chicago, IL, p.A1802 Bronchodilator Response Test in Mechanically Ventilated COPD Patients: A Two Phase Study/J. Li, B. Sun, J. Duan, Q. Zhan, H. Dai, J.B. Fink, C. Wang, Chicago, IL, p.A1803 Endotracheal Tube Position Confirmation by the Bedside Ultrasound in Respiratory Intensive Care Unit Patients/W. Lei, F. Dong, J. Wang, Y. Zhu, J. Huang, Suzhou, China, p.A1804 Facilitators: M.T. Kearns, MD, Aurora, CO A.M. Luks, MD, Seattle, WA P907 P908 P909 P910 P911 P912 P913 Level of Fellowship Training Is Associated with Independent Procedure Performance in Endotracheal Intubation of Critically Ill Adults/M.B. Fashho, M.W. Semler, T.W. Rice, B. DeBoisblanc, D. Janz, New Orleans, LA, p.A1805 The “Waterfall Sign”: A Novel M-Mode Thoracic Ultrasound Sign to Objectively Quantify B Lines/V. Sharma, E. Christian, R. Gueret, J. Bailitz, Chicago, IL, p.A1806 Can Exhaled Breath Condensate Be Used to Seek A Mitochondrial DNA Signature for Acute Respiratory Distress Syndrome?/A. Harriott, R. Bascom, A.E.F. Dimmock, T. Kuhlengel, J.A. Howrylak, Hershey, PA, p.A1807 Accuracy of Arterial Blood Gas (ABG) Hemoglobin in the Intensive Care Unit (ICU)/N. Jiramethee, A. Lee, Jacksonville, FL, p.A1808 Comparison of Arterial and Venous Blood Gases: Correlation in a General Patient Population/A. Scavone, A. Ahmed, K. Kuchta, S. Bellam, Evanston, IL, p.A1809 Questioning the Utility of Central Venous and Arterial Catheters in the Management of Sepsis/S.G. Pape, J. Lascano, J. Chertoff, Gainesville, FL, p.A1810 Standard and Deferred Consent in the Age of Transfused Blood (ABLE) Trial in Critically Ill Adults/K.E.A. Burns, P. Hebert, D. Fergusson, J. Lacroix, Toronto, Canada, p.A1811 SUNDAY MORNING ATS 2016 • San Francisco
- Page 1 and 2:
American Thoracic Society Internati
- Page 3:
TABLE OF CONTENTS ATS 2016 INTERNAT
- Page 6 and 7:
2 FRIDAY • MAY 13 PG2A CLINICAL P
- Page 8 and 9:
4 FRIDAY • MAY 13 Target Audience
- Page 10 and 11:
6 FRIDAY • MAY 13 11:15 Case Disc
- Page 12 and 13:
8 FRIDAY • MAY 13 Chairing: H.B.
- Page 14 and 15:
10 FRIDAY • MAY 13 10:25 Advanced
- Page 16 and 17:
12 FRIDAY • MAY 13 Objectives At
- Page 18 and 19:
14 SATURDAY • MAY 14 Abdominal Ul
- Page 20 and 21:
16 SATURDAY • MAY 14 PG17 BASIC
- Page 22 and 23: 18 SATURDAY • MAY 14 1:05 In What
- Page 24 and 25: 20 SATURDAY • MAY 14 10:30 Practi
- Page 26 and 27: 22 SATURDAY • MAY 14 Objectives A
- Page 28 and 29: 24 SATURDAY • MAY 14 10:10 Is My
- Page 30 and 31: 26 SUNDAY • MAY 15 Chairing: D.M.
- Page 32 and 33: 28 SUNDAY • MAY 15 Chronic Cough:
- Page 34 and 35: 30 SUNDAY • MAY 15 • understand
- Page 36 and 37: 32 SUNDAY • MAY 15 Target Audienc
- Page 38 and 39: 34 SUNDAY • MAY 15 Oral Presentat
- Page 40 and 41: 36 SUNDAY • MAY 15 9:15 Hyperpola
- Page 42 and 43: 38 SUNDAY • MAY 15 310 A Smartpho
- Page 44 and 45: 40 SUNDAY • MAY 15 103 Immunosupp
- Page 46 and 47: 42 SUNDAY • MAY 15 A26 POSTER DIS
- Page 48 and 49: 44 SUNDAY • MAY 15 822 Incidence
- Page 50 and 51: 46 SUNDAY • MAY 15 519 Maternal H
- Page 52 and 53: 48 SUNDAY • MAY 15 P14 P15 P16 P1
- Page 54 and 55: 50 SUNDAY • MAY 15 P1545 P1546 Fa
- Page 56 and 57: 52 SUNDAY • MAY 15 P60 P61 Facili
- Page 58 and 59: 54 SUNDAY • MAY 15 P149 P150 Faci
- Page 60 and 61: 56 SUNDAY • MAY 15 P749 P750 P751
- Page 62 and 63: 58 SUNDAY • MAY 15 Facilitator: P
- Page 64 and 65: 60 SUNDAY • MAY 15 P1243 P1244 P1
- Page 66 and 67: 62 SUNDAY • MAY 15 P1295 P1296 P1
- Page 68 and 69: 64 SUNDAY • MAY 15 P1358 P1359 P1
- Page 70 and 71: 66 SUNDAY • MAY 15 P91 Facilitato
- Page 74 and 75: 70 SUNDAY • MAY 15 P914 P915 P916
- Page 76 and 77: 72 SUNDAY • MAY 15 P556 P557 P558
- Page 78 and 79: 74 SUNDAY • MAY 15 Facilitators:
- Page 80 and 81: 76 SUNDAY • MAY 15 P997 P998 P999
- Page 82 and 83: 78 SUNDAY • MAY 15 P256 P257 P258
- Page 84 and 85: 80 SUNDAY • MAY 15 A61 THEMATIC P
- Page 86 and 87: 82 SUNDAY • MAY 15 P824 Facilitat
- Page 88 and 89: 84 SUNDAY • MAY 15 P1055 P1056 P1
- Page 90 and 91: 86 SUNDAY • MAY 15 P1101 P1102 P1
- Page 92 and 93: 88 SUNDAY • MAY 15 P1423 P1424 P1
- Page 94 and 95: 90 SUNDAY • MAY 15 P1474 P1475 P1
- Page 96 and 97: 92 SUNDAY • MAY 15 P377 P378 P379
- Page 98 and 99: 94 SUNDAY • MAY 15 P281 P282 P283
- Page 100 and 101: 96 SUNDAY • MAY 15 P450 P451 A74
- Page 102 and 103: 98 SUNDAY • MAY 15 P1562 P1563 P1
- Page 104 and 105: 100 SUNDAY • MAY 15 A80-A THEMATI
- Page 106 and 107: 102 SUNDAY • MAY 15 Facilitator:
- Page 108 and 109: 104 SUNDAY • MAY 15 11:00 a.m.-12
- Page 110 and 111: 106 SUNDAY • MAY 15 L1 U.S. FOOD
- Page 112 and 113: 108 SUNDAY • MAY 15 12:15 Post-Pr
- Page 114 and 115: 110 SUNDAY • MAY 15 MP406 MP407 M
- Page 116 and 117: 112 SUNDAY • MAY 15 clinician and
- Page 118 and 119: 114 SUNDAY • MAY 15 A86 BASIC •
- Page 120 and 121: 116 SUNDAY • MAY 15 Chairing: M.J
- Page 122 and 123:
118 SUNDAY • MAY 15 3:30 High Pre
- Page 124 and 125:
120 SUNDAY • MAY 15 102 Toll-Like
- Page 126 and 127:
122 SUNDAY • MAY 15 A103 POSTER D
- Page 128 and 129:
124 SUNDAY • MAY 15 719 Lactate R
- Page 130 and 131:
126 SUNDAY • MAY 15 1014 Determin
- Page 132 and 133:
128 SUNDAY • MAY 15 611 Plasma Mi
- Page 134 and 135:
130 SUNDAY • MAY 15 412 Daytime S
- Page 136 and 137:
132 SUNDAY • MAY 15 6:30 p.m. - 8
- Page 138 and 139:
134 MONDAY • MAY 16 SS111 SS112 S
- Page 140 and 141:
136 MONDAY • MAY 16 Target Audien
- Page 142 and 143:
138 MONDAY • MAY 16 9:40 Empoweri
- Page 144 and 145:
140 MONDAY • MAY 16 9:28 Endotoxi
- Page 146 and 147:
142 MONDAY • MAY 16 10:15 Adaptiv
- Page 148 and 149:
144 MONDAY • MAY 16 Oral Presenta
- Page 150 and 151:
146 MONDAY • MAY 16 624 Neonatal
- Page 152 and 153:
148 MONDAY • MAY 16 118 Compariso
- Page 154 and 155:
150 MONDAY • MAY 16 912 Should Pa
- Page 156 and 157:
152 MONDAY • MAY 16 1015 Resverat
- Page 158 and 159:
154 MONDAY • MAY 16 718 Health Re
- Page 160 and 161:
156 MONDAY • MAY 16 P152 Facilita
- Page 162 and 163:
158 MONDAY • MAY 16 B35 THEMATIC
- Page 164 and 165:
160 MONDAY • MAY 16 P252 P253 P25
- Page 166 and 167:
162 MONDAY • MAY 16 P406 P407 P40
- Page 168 and 169:
164 MONDAY • MAY 16 P320 Bilatera
- Page 170 and 171:
166 MONDAY • MAY 16 B40 THEMATIC
- Page 172 and 173:
168 MONDAY • MAY 16 P528 P529 Fac
- Page 174 and 175:
170 MONDAY • MAY 16 Facilitator:
- Page 176 and 177:
172 MONDAY • MAY 16 B44 THEMATIC
- Page 178 and 179:
174 MONDAY • MAY 16 P484 P485 P48
- Page 180 and 181:
176 MONDAY • MAY 16 P1161 P1162 P
- Page 182 and 183:
178 MONDAY • MAY 16 B48 THEMATIC
- Page 184 and 185:
180 MONDAY • MAY 16 P1238 P1239 P
- Page 186 and 187:
182 MONDAY • MAY 16 P1297 P1298 P
- Page 188 and 189:
184 MONDAY • MAY 16 Facilitator:
- Page 190 and 191:
186 MONDAY • MAY 16 P15 P16 P17 P
- Page 192 and 193:
188 MONDAY • MAY 16 Facilitator:
- Page 194 and 195:
190 MONDAY • MAY 16 P114 P115 P11
- Page 196 and 197:
192 MONDAY • MAY 16 P1408 Enhance
- Page 198 and 199:
194 MONDAY • MAY 16 P1455 P1456 P
- Page 200 and 201:
196 MONDAY • MAY 16 P1487 P1488 P
- Page 202 and 203:
198 MONDAY • MAY 16 P1514 P1515 P
- Page 204 and 205:
200 MONDAY • MAY 16 Facilitator:
- Page 206 and 207:
202 MONDAY • MAY 16 P559 P560 P56
- Page 208 and 209:
204 MONDAY • MAY 16 WS3 CLINICAL
- Page 210 and 211:
206 MONDAY • MAY 16 Satellite ear
- Page 212 and 213:
208 MONDAY • MAY 16 Objectives At
- Page 214 and 215:
210 MONDAY • MAY 16 encourage tra
- Page 216 and 217:
212 MONDAY • MAY 16 B82 BEHAVIORA
- Page 218 and 219:
214 MONDAY • MAY 16 B86 BASIC •
- Page 220 and 221:
216 MONDAY • MAY 16 and a number
- Page 222 and 223:
218 MONDAY • MAY 16 2:30 Mortalit
- Page 224 and 225:
220 MONDAY • MAY 16 3:00 Simultan
- Page 226 and 227:
222 MONDAY • MAY 16 525 Clinical
- Page 228 and 229:
224 MONDAY • MAY 16 320 Sensitivi
- Page 230 and 231:
226 MONDAY • MAY 16 113 COPD Subt
- Page 232 and 233:
228 MONDAY • MAY 16 1004 Health C
- Page 234 and 235:
230 MONDAY • MAY 16 609 Skeletal
- Page 236 and 237:
232 MONDAY • MAY 16 5:00 p.m. - 7
- Page 238 and 239:
234 TUESDAY • MAY 17 Chairing: D.
- Page 240 and 241:
236 TUESDAY • MAY 17 CLINICAL YEA
- Page 242 and 243:
238 TUESDAY • MAY 17 This session
- Page 244 and 245:
240 TUESDAY • MAY 17 bronchiectas
- Page 246 and 247:
242 TUESDAY • MAY 17 Target Audie
- Page 248 and 249:
244 TUESDAY • MAY 17 C18 MINI SYM
- Page 250 and 251:
246 TUESDAY • MAY 17 415 Investig
- Page 252 and 253:
248 TUESDAY • MAY 17 207 Survival
- Page 254 and 255:
250 TUESDAY • MAY 17 906 Phenotyp
- Page 256 and 257:
252 TUESDAY • MAY 17 807 The Vali
- Page 258 and 259:
254 TUESDAY • MAY 17 515 Roles of
- Page 260 and 261:
256 TUESDAY • MAY 17 P383 P384 P3
- Page 262 and 263:
258 TUESDAY • MAY 17 Facilitator:
- Page 264 and 265:
260 TUESDAY • MAY 17 P199 P200 P2
- Page 266 and 267:
262 TUESDAY • MAY 17 P620 Facilit
- Page 268 and 269:
264 TUESDAY • MAY 17 P428 P429 P4
- Page 270 and 271:
266 TUESDAY • MAY 17 P442 P443 P4
- Page 272 and 273:
268 TUESDAY • MAY 17 P318 P319 P3
- Page 274 and 275:
270 TUESDAY • MAY 17 P474 P475 Fa
- Page 276 and 277:
272 TUESDAY • MAY 17 Facilitator:
- Page 278 and 279:
274 TUESDAY • MAY 17 P727 P728 P7
- Page 280 and 281:
276 TUESDAY • MAY 17 P774 P775 Fa
- Page 282 and 283:
278 TUESDAY • MAY 17 C53 THEMATIC
- Page 284 and 285:
280 TUESDAY • MAY 17 C55 THEMATIC
- Page 286 and 287:
282 TUESDAY • MAY 17 P1095 P1096
- Page 288 and 289:
284 TUESDAY • MAY 17 P1167 P1168
- Page 290 and 291:
286 TUESDAY • MAY 17 P632 P633 P6
- Page 292 and 293:
288 TUESDAY • MAY 17 P546 P547 P5
- Page 294 and 295:
290 TUESDAY • MAY 17 Facilitator:
- Page 296 and 297:
292 TUESDAY • MAY 17 C65 THEMATIC
- Page 298 and 299:
294 TUESDAY • MAY 17 P659 P660 P6
- Page 300 and 301:
296 TUESDAY • MAY 17 P1506 P1507
- Page 302 and 303:
298 TUESDAY • MAY 17 C70 THEMATIC
- Page 304 and 305:
300 TUESDAY • MAY 17 P1363 P1364
- Page 306 and 307:
302 TUESDAY • MAY 17 P928 P929 P9
- Page 308 and 309:
304 TUESDAY • MAY 17 P973 P974 Fa
- Page 310 and 311:
306 TUESDAY • MAY 17 Facilitator:
- Page 312 and 313:
308 TUESDAY • MAY 17 C80 THEMATIC
- Page 314 and 315:
310 TUESDAY • MAY 17 P98 P99 P100
- Page 316 and 317:
312 TUESDAY • MAY 17 • become a
- Page 318 and 319:
314 TUESDAY • MAY 17 The topics a
- Page 320 and 321:
316 TUESDAY • MAY 17 C85 BASIC
- Page 322 and 323:
318 TUESDAY • MAY 17 C89 BASIC
- Page 324 and 325:
320 TUESDAY • MAY 17 3:20 Pediatr
- Page 326 and 327:
322 TUESDAY • MAY 17 2:45 Long-Te
- Page 328 and 329:
324 TUESDAY • MAY 17 918 Sarcoido
- Page 330 and 331:
326 TUESDAY • MAY 17 410 Effectiv
- Page 332 and 333:
328 TUESDAY • MAY 17 710 Follista
- Page 334 and 335:
330 TUESDAY • MAY 17 509 A Mechan
- Page 336 and 337:
332 TUESDAY • MAY 17 806 Upper Ai
- Page 338 and 339:
334 WEDNESDAY • MAY 18 6:45 Acute
- Page 340 and 341:
336 WEDNESDAY • MAY 18 CLINICAL Y
- Page 342 and 343:
338 WEDNESDAY • MAY 18 Objectives
- Page 344 and 345:
340 WEDNESDAY • MAY 18 D9 BASIC
- Page 346 and 347:
342 WEDNESDAY • MAY 18 Oral Prese
- Page 348 and 349:
344 WEDNESDAY • MAY 18 10:15 Plas
- Page 350 and 351:
346 WEDNESDAY • MAY 18 419 A Nove
- Page 352 and 353:
348 WEDNESDAY • MAY 18 216 Simpli
- Page 354 and 355:
350 WEDNESDAY • MAY 18 815 Multip
- Page 356 and 357:
352 WEDNESDAY • MAY 18 D28 POSTER
- Page 358 and 359:
354 WEDNESDAY • MAY 18 720 Repeat
- Page 360 and 361:
356 WEDNESDAY • MAY 18 P389 Facil
- Page 362 and 363:
358 WEDNESDAY • MAY 18 P439 P440
- Page 364 and 365:
360 WEDNESDAY • MAY 18 P10 P11 P1
- Page 366 and 367:
362 WEDNESDAY • MAY 18 P52 P53 Fa
- Page 368 and 369:
364 WEDNESDAY • MAY 18 P95 P96 P9
- Page 370 and 371:
366 WEDNESDAY • MAY 18 P698 P699
- Page 372 and 373:
368 WEDNESDAY • MAY 18 D42 THEMAT
- Page 374 and 375:
370 WEDNESDAY • MAY 18 P748 Funge
- Page 376 and 377:
372 WEDNESDAY • MAY 18 P353 P354
- Page 378 and 379:
374 WEDNESDAY • MAY 18 P172 P173
- Page 380 and 381:
376 WEDNESDAY • MAY 18 P808 Facil
- Page 382 and 383:
378 WEDNESDAY • MAY 18 P526 P527
- Page 384 and 385:
380 WEDNESDAY • MAY 18 P579 P580
- Page 386 and 387:
382 WEDNESDAY • MAY 18 P944 P945
- Page 388 and 389:
384 WEDNESDAY • MAY 18 P991 P992
- Page 390 and 391:
386 WEDNESDAY • MAY 18 P1036 P103
- Page 392 and 393:
388 WEDNESDAY • MAY 18 P1062 P106
- Page 394 and 395:
390 WEDNESDAY • MAY 18 11:45 Intr
- Page 396 and 397:
392 WEDNESDAY • MAY 18 12:15 Upda
- Page 398 and 399:
394 WEDNESDAY • MAY 18 This sessi
- Page 400 and 401:
396 WEDNESDAY • MAY 18 1:30 The B
- Page 402 and 403:
398 WEDNESDAY • MAY 18 D88 BEHAVI
- Page 404 and 405:
400 WEDNESDAY • MAY 18 3:00 Accel
- Page 406 and 407:
402 WEDNESDAY • MAY 18 D96 MINI S
- Page 408 and 409:
404 WEDNESDAY • MAY 18 604 CARMA3
- Page 410 and 411:
406 WEDNESDAY • MAY 18 702 Potent
- Page 412 and 413:
408 WEDNESDAY • MAY 18 803 ICU Ac
- Page 414 and 415:
410 WEDNESDAY • MAY 18 Chairing:
- Page 416 and 417:
412 WEDNESDAY • MAY 18 404 Interm
- Page 418:
Where today’s science meets tomor